Mutagenicity assessment of two potential impurities in preparations of 5-amino-2,4,6 triiodoisophthalic acid, a key intermediate in the synthesis of the iodinated contrast agent iopamidol

Mutat Res Genet Toxicol Environ Mutagen. 2024 Jan:893:503720. doi: 10.1016/j.mrgentox.2023.503720. Epub 2023 Nov 28.

Abstract

5-Aminoisophthalic acid and 5-nitroisophthalic acid (5-NIPA) are potential impurities in preparations of 5-amino-2,4,6-triiodoisophthalic acid, which is a key intermediate in the synthesis of the iodinated contrast agent iopamidol. We have studied their mutagenicity in silico (quantitative structure-activity relationships, QSAR) and by the bacterial reverse mutation assay (Ames test). First, the compounds were screened with the tools Derek Nexus™ and Leadscope®. Both compounds were flagged as potentially mutagenic (class 3 under ICH M7). However, contrary to the in silico prediction, neither chemical was mutagenic in the Ames test (plate incorporation method) with or without S9 metabolic activation.

Keywords: Ames; Derek Nexus; Impurity; In silico mutagenicity; In vitro mutagenicity.

MeSH terms

  • Computer Simulation
  • Contrast Media* / toxicity
  • Iopamidol / toxicity
  • Mutagenicity Tests / methods
  • Mutagens* / chemistry
  • Mutagens* / toxicity

Substances

  • Mutagens
  • Contrast Media
  • Iopamidol